Genetic test can identify how patients with triple negative early-stage breast cancer

[News]

Researchers have developed a genetic test that can identify how patients with triple negative early-stage breast cancer will respond to immunotherapy drugs.

More... (https://www.news-medical.net/news/20240320/Genetic-test-can-identify-how-patients-with-triple-negative-early-stage-breast-cancer-will-respond-to-immunotherapy.aspx)